Navigate this market better. Subscribe for FREE stock alerts and information.

Wednesday, January 29, 2014

Biogen profit rises as new multiple sclerosis drug shines, (NASDAQ: BIIB), (NYSE: TRI), (TSE: TRI.TO)

Biogen Idec Inc said on Wednesday its new, high-profile oral multiple sclerosis drug Tecfidera had sales of $398 million in the fourth quarter, easily exceeding estimates for a third successive quarter and keeping it on track to top $1 billion in its first year on the market.Some of those sales were due to U.S. inventory stocking ahead of a 10 percent Tecfidera price increase in December. Biogen said underlying patient demand for the drug represented about $348 million of the U.S. sales, still ahead of analysts' consensus expectations of about $335 million.Biogen provided forecasts for 2014 that were likely to be viewed as a mixed bag, with revenue growth projections ahead of Wall Street expectations but an earnings outlook that fell short of the current analysts' view.The company forecast revenue growth of about 22 percent to 25 percent and earnings of $11 to $11.20 per share, excluding items. Analysts, on average, were looking for revenue growth of about 20 percent and earnings of $11.63 per share, according to Thomson Reuters I/B/E/S.

Biogen Idec Inc. (Biogen Idec) is a global biotechnology company. Shares of BIIB remained unchanged at $305.65. In the past year, the shares have traded as low as $152.92 and as high as $315.38. On average, 1278390 shares of BIIB exchange hands on a given day and today's volume is recorded at 6114.

Thomson Reuters Corporation (Thomson Reuters) is a provider of information for the world?s businesses and professionals. Shares of TRI remained unchanged at $36.13. In the past year, the shares have traded as low as $29.33 and as high as $38.73. On average, 730682 shares of TRI exchange hands on a given day and today's volume is recorded at 0.

Thomson Reuters Corporation (Thomson Reuters) is a provider of information for the world?s businesses and professionals. Shares of TRI traded higher by 0.45% or $0.18/share to $40.31. In the past year, the shares have traded as low as $29.40 and as high as $42.10. On average, 904041 shares of TRI.TO exchange hands on a given day and today's volume is recorded at 595174.



Source